| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2025 | 22 May 2025 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we here inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Tuesday May 27 2025 inter-alia to consider/approve the following matters: (i) The Audited Standalone Financial Results of the Company for the Fourth quarter (Q4) and year ended March 31 2025 along with the Audited report. (ii) Appointment of Internal Auditors of the Company for the Financial Year 2025-26. (iii) Any other business as the Board deemed fit to discuss with the permission of the chair and majority of directors present in the meeting. Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, i.e Tuesday, May 27, 2025, has transacted and approved the following business, inter alia attached herewith The Board meeting commenced at 14:15 P.M. (IST) and discussions on the above agenda items concluded at 15:45 P.M. (IST). The same will also be made available on the Companys website at www.ayokimerchantile.com You are requested to kindly take note of above and bring the same to the notice of investors and members. (As Per BSE Announcement Dated on: 27/05/2025) | ||
| Board Meeting | 12 May 2025 | 6 May 2025 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we here inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Monday May 12 2025 inter-alia to consider/approve the following matters: (i) Appointment of Company Secretary and Compliance Officer of the Company. (ii) Reconstitution of Committees of Board. (iii) Any other matter with the permission of the Chair and majority of directors present in the meeting. Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, i.e Monday, May 12, 2025, has transacted and approved the following business, inter alia attached herewith for your reference (As Per BSE Announcement dated on 12.05.2025) | ||
| Board Meeting | 10 Feb 2025 | 1 Feb 2025 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the Quarter and Nine Months ended December 31 2024 along with the Limited Review Report. Pursuant to Regulations 30 & 33 read with Schedule III of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, i.e Monday, February 10, 2025, has transacted and approved the following business, inter alia attached herewith (As Per BSE Announcement Dated on 10/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Unaudited Standalone Financial Result for the Quarter and Half year ended on September 30 2024 please find enclosed herewith the out comes of Board meeting (As Per Bse Announcement Dated on 14.11.2024) | ||
| Board Meeting | 16 Sep 2024 | 10 Sep 2024 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/09/2024 ,inter alia, to consider and approve the Proposal for Raising of Funds by way of the Issue of Equity Shares. Please find enclosed the Outcome of the Board Meeting held on 16-09-2024 (As Per BSE Announcement dated on 16.09.2024) | ||
| Board Meeting | 11 Sep 2024 | 6 Sep 2024 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/09/2024 inter alia to consider and approve the proposal for raising of funds by way of the issue of equity shares convertible securities and / or any other eligible securities on a rights / preferential basis or any other permissible mode / and / or combination thereof as may be considered appropriate The Board Meeting to be held on 11/09/2024 Stands Cancelled. (As Per NSE Announcement Dated on: 10/09/2024) | ||
| Board Meeting | 6 Sep 2024 | 6 Sep 2024 |
| Please find enclosed the Outcomes of Board Meeting held on 06/09/2024 | ||
| Board Meeting | 29 Aug 2024 | 29 Aug 2024 |
| Please find enclosed the Outcomes of Board Meeting held on August 29, 2024 | ||
| Board Meeting | 14 Aug 2024 | 8 Aug 2024 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve (i) Unaudited Financial Results of the Company for the Quarter ended on June 30 2024 of the current financial year 2024-25 along with the Limited Review Report thereon. (ii) To approve the Notice of the Annual General Meeting and Board Report along with other related documents for the forthcoming Annual General Meeting of the Company for the financial year ending on March 31 2024. (iii) To appoint Mr. Kamal A. Lalani Practicing Company Secretary as a scrutinizer for conducting e-voting at the 40th Annual General Meeting of the company. (iv) Any other matter with the permission of the Chair and majority of directors present in the meeting. please find enclosed herewith the Unaudited Standalone Financial Result for the Quarter ended on June 30, 2024 of the current Financial year 2024-25 (As Per BSE Announcement Dated on 14.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.